Here is today's mail:
- A letter from EmblemHealth
Informing us that now that Atorvastatin, a generic form of Lipitor is available, they will no longer cover Lipitor without prior approval, and it will only be covered as a nonpreferred brand. Of course, that means a higher copay. The problem is that Pfizer was subsidizing the cost of Lipitor so that the copay was only $4, and now we will pay more for the generic than we did for the name brand.
- A fundraising appeal from the Jewish National Fund
- A fundraising appeal from the Federation of Jewish Men's Clubs
- The Spring/Summer edition of The Great Neck Public Schools Adult Program Continuing Education catalogue
- A copy of Homes & Estates Magazine
- A Semi-Annual Report from First Trust Senior Floating Rate Income Fund II
- This week's edition of The Great Neck Record
No comments:
Post a Comment